\-\ Texto\\:\\ \ \(0\)\
\-\ patient\\ is\\ afebrile\\ with\\ an\\ unremarkable\\ physical\\ exam\\.\\ \\ no\\ recent\\ labs\ \(0\)\
\-\ young\\ children\\ with\\ stage\\ i\\ and\\ ii\\ reflux\\ can\\ usually\\ be\\ managed\\ medically\\ with\\ daily\\ prophylactic\\ antibiotics\\ and\\ followed\\ with\\ periodic\\ urine\\ cultures\\.\\ \\ approximately\\ 80\\%\\ of\\ these\\ children\\ will\\ have\\ resolution\\ of\\ reflux\\ within\\ 5\\ years\\.\\ \\ treatment\\ of\\ this\\ patient\\ should\\ include\\ daily\\ trimethoprim\\/sulfamethoxazole\\ or\\ nitrofurantoin\\ for\\ antimicrobial\\ prophylaxis\\ and\\ regular\\ urine\\ cultures\\ at\\ 1\\-3\\ month\\ intervals\\ until\\ 3\\ consecutive\\ cultures\\ are\\ negative\\.\\ \\ prophylaxis\\ should\\ be\\ continued\\ until\\ reflux\\ resolves\\ as\\ determined\\ by\\ annual\\ radionuclide\\ cystography\\.\ \(0\)\
\-\ voiding\\ cystourethrogram\\ \\(vcug\\)\\ shows\\ vesicoureteral\\ reflux\\ of\\ contrast\\ on\\ the\\ right\\ side\\ during\\ filling\\.\\ \\ the\\ contrast\\ extends\\ from\\ the\\ vesicoureteral\\ junction\\ to\\ the\\ central\\ collecting\\ system\\ showing\\ a\\ nondilated\\ ureter\\ and\\ renal\\ pelvis\\ with\\ normal\\ calyceal\\ fornices\\.\\ \\ no\\ vesicoureteral\\ reflux\\ is\\ seen\\ on\\ the\\ left\\ side\\.\ \(0\)\
\-\ right\\ grade\\ ii\\ vesicoureteral\\ reflux\ \(0\)\
\-\ right\\ grade\\ ii\\ vesicoureteral\\ reflux\ \(0\)\
\-\ 5\\ year\\-old\\ girl\\ with\\ history\\ of\\ treated\\ febrile\\,\\ right\\-sided\\ pyelonephritis\\ \\(culture\\ positive\\ for\\ \\>100\\,000\\ colony\\ forming\\ units\\ e\\.\\ coli\\)\\.\\ \\ family\\ history\\ of\\ vesicoureteral\\ reflux\ \(0\)\
\-\ demonstration\\ of\\ vesicoureteral\\ reflux\\ requires\\ either\\ a\\ voiding\\ cystourethrogram\\ \\(vcug\\)\\ or\\ a\\ radionuclide\\ cystogram\\ \\(rnc\\)\\,\\ and\\ long\\ term\\ complications\\ of\\ this\\ condition\\ include\\ recurrent\\ pyelonephritis\\,\\ renal\\ scarring\\,\\ end\\-stage\\ renal\\ failure\\,\\ and\\ late\\ secondary\\ hypertension\\.\\ \\ therefore\\ it\\ is\\ recommended\\ that\\ all\\ children\\ under\\ age\\ 7\\ with\\ a\\ first\\ uti\\ should\\ undergo\\ a\\ vcug\\ for\\ diagnosis\\ and\\ classification\\ of\\ reflux\\.1\\ \\ \\ \\ \\ international\\ classification\\ of\\ vesicoureteral\\ reflux\\:\\ \\ grade\\ i\\:\\ ureter\\ only\\ \\ grade\\ ii\\:\\ ureter\\,\\ pelvis\\,\\ and\\ calyces\\;\\ no\\ dilation\\,\\ normal\\ calyceal\\ fornices\\ \\ grade\\ iii\\:\\ mild\\ to\\ moderate\\ dilation\\ or\\ tortuosity\\ of\\ the\\ ureter\\/renal\\ pelvis\\;\\ slight\\ or\\ no\\ blunting\\ of\\ the\\ fornices\\ \\ grade\\ iv\\:\\ moderate\\ dilation\\ or\\ tortuosity\\ of\\ the\\ ureter\\/renal\\ pelvis\\;\\ complete\\ obliteration\\ of\\ sharp\\ angle\\ of\\ fornices\\,\\ but\\ maintenance\\ of\\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ papillary\\ impressions\\ in\\ majority\\ of\\ calyces\\.\\ \\ grade\\ v\\:\\ gross\\ dilation\\ and\\ tortuosity\\ of\\ ureter\\/renal\\ pelvis\\;\\ papillary\\ impressions\\ are\\ no\\ longer\\ visible\\ in\\ the\\ majority\\ of\\ calyces\\.treatment\\ of\\ children\\ with\\ grades\\ 1\\-ii\\ reflux\\ is\\ usually\\ medical\\ therapy\\ with\\ prophylactic\\ antimicrobials\\ and\\ close\\ follow\\-up\\ \\(as\\ described\\ above\\ for\\ this\\ patient\\)\\.2\\ \\ surgical\\ options\\ \\(often\\ in\\ conjunction\\ with\\ medical\\ therapy\\)\\ exist\\ for\\ more\\ severe\\ reflux\\ \\(grades\\ iii\\-v\\)\\,\\ usually\\ consisting\\ of\\ open\\ surgical\\ reimplantation\\ of\\ the\\ vesicoureteral\\ junction\\,\\ although\\ some\\ investigations\\ of\\ less\\ invasive\\ techniques\\ are\\ promising\\.\\ \\ these\\ newer\\ techniques\\ include\\ laparoscopic\\ reimplantation\\ as\\ well\\ as\\ endoscopic\\ injection\\ of\\ materials\\ \\(e\\.g\\.\\ teflon\\)\\ behind\\ the\\ ureter\\ to\\ provide\\ a\\ valve\\ mechanism\\ during\\ bladder\\ filling\\ and\\ emptying\\.3\\,4\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ reflux\\:\\ 0\\.41725184540033755\ \(0\)\
\-\ vesicoureteral\\:\\ 0\\.3627884166584001\ \(0\)\
\-\ ureter\\:\\ 0\\.2544923814874224\ \(0\)\
\-\ fornices\\:\\ 0\\.1952382003802128\ \(0\)\
\-\ grade\\:\\ 0\\.18654061383330392\ \(0\)\
\-\ of\\:\\ 0\\.17405486030932948\ \(0\)\
\-\ ii\\:\\ 0\\.14609400322634367\ \(0\)\
\-\ tortuosity\\:\\ 0\\.14131521661044685\ \(0\)\
\-\ renal\\:\\ 0\\.1384661872700891\ \(0\)\
\-\ dilation\\:\\ 0\\.13044868216239303\ \(0\)\
\-\ pelvis\\:\\ 0\\.12959651209796824\ \(0\)\
\-\ calyces\\:\\ 0\\.12936591755427593\ \(0\)\
\-\ vcug\\:\\ 0\\.12567762404530405\ \(0\)\
\-\ children\\:\\ 0\\.12146067609263725\ \(0\)\
\-\ impressions\\:\\ 0\\.1132625799238372\ \(0\)\
\-\ cultures\\:\\ 0\\.10471913466668988\ \(0\)\
\-\ grades\\:\\ 0\\.10225345508332924\ \(0\)\
\-\ cystourethrogram\\:\\ 0\\.09898807221796828\ \(0\)\
\-\ reimplantation\\:\\ 0\\.09638071435545131\ \(0\)\
\-\ calyceal\\:\\ 0\\.09151224111283512\ \(0\)\
\-\ radionuclide\\:\\ 0\\.0907245322548419\ \(0\)\
\-\ voiding\\:\\ 0\\.08998186058875053\ \(0\)\
\-\ and\\:\\ 0\\.08423571657054073\ \(0\)\
\-\ prophylaxis\\:\\ 0\\.08171832062562415\ \(0\)\
\-\ the\\:\\ 0\\.08134078664773993\ \(0\)\
\-\ prophylactic\\:\\ 0\\.08097564895953278\ \(0\)\
\-\ techniques\\:\\ 0\\.07897273574824257\ \(0\)\
\-\ pyelonephritis\\:\\ 0\\.07696982253695236\ \(0\)\
\-\ classification\\:\\ 0\\.07619772114852907\ \(0\)\
\-\ with\\:\\ 0\\.07256619085287055\ \(0\)\
\-\ should\\:\\ 0\\.07254302128268163\ \(0\)\
\-\ daily\\:\\ 0\\.07027962883235812\ \(0\)\
\-\ usually\\:\\ 0\\.06999007520036067\ \(0\)\
\-\ papillary\\:\\ 0\\.06907008477836855\ \(0\)\
\-\ majority\\:\\ 0\\.06731704882301802\ \(0\)\
\-\ urine\\:\\ 0\\.06634514044044221\ \(0\)\
\-\ include\\:\\ 0\\.06614933541798747\ \(0\)\
\-\ or\\:\\ 0\\.06446086286171343\ \(0\)\
\-\ iii\\:\\ 0\\.06399572091167958\ \(0\)\
\-\ until\\:\\ 0\\.061675716114715895\ \(0\)\
\-\ no\\:\\ 0\\.06025585529974036\ \(0\)\
\-\ as\\:\\ 0\\.05955169152551944\ \(0\)\
\-\ junction\\:\\ 0\\.05936136601845675\ \(0\)\
\-\ colony\\:\\ 0\\.05926543800024418\ \(0\)\
\-\ rnc\\:\\ 0\\.05926543800024418\ \(0\)\
\-\ antimicrobials\\:\\ 0\\.05926543800024418\ \(0\)\
\-\ teflon\\:\\ 0\\.05926543800024418\ \(0\)\
\-\ stage\\:\\ 0\\.05902386089071367\ \(0\)\
\-\ filling\\:\\ 0\\.05739758903210034\ \(0\)\
\-\ for\\:\\ 0\\.056161520121649794\ \(0\)\
\-\ moderate\\:\\ 0\\.05564055806132366\ \(0\)\
\-\ nitrofurantoin\\:\\ 0\\.05476233218563531\ \(0\)\
\-\ promising\\:\\ 0\\.05476233218563531\ \(0\)\
\-\ nondilated\\:\\ 0\\.053312655909662075\ \(0\)\
\-\ materials\\:\\ 0\\.053312655909662075\ \(0\)\
\-\ consecutive\\:\\ 0\\.05212818414730973\ \(0\)\
\-\ side\\:\\ 0\\.0512028386375869\ \(0\)\
\-\ cystography\\:\\ 0\\.05112672754166462\ \(0\)\
\-\ antimicrobial\\:\\ 0\\.04949403610898414\ \(0\)\
\-\ cystogram\\:\\ 0\\.04949403610898414\ \(0\)\
\-\ investigations\\:\\ 0\\.04949403610898414\ \(0\)\
\-\ right\\:\\ 0\\.04914639162982041\ \(0\)\
\-\ newer\\:\\ 0\\.0488095500950532\ \(0\)\
\-\ medical\\:\\ 0\\.0471049771626581\ \(0\)\
\-\ during\\:\\ 0\\.04694619860609717\ \(0\)\
\-\ intervals\\:\\ 0\\.046623621727055746\ \(0\)\
\-\ resolves\\:\\ 0\\.046623621727055746\ \(0\)\
\-\ maintenance\\:\\ 0\\.04617540205672761\ \(0\)\
\-\ international\\:\\ 0\\.044990930294375266\ \(0\)\
\-\ coli\\:\\ 0\\.04398947368873016\ \(0\)\
\-\ conjunction\\:\\ 0\\.04398947368873016\ \(0\)\
\-\ exist\\:\\ 0\\.04398947368873016\ \(0\)\
\-\ blunting\\:\\ 0\\.04339846566778924\ \(0\)\
\-\ medically\\:\\ 0\\.043121972518091974\ \(0\)\
\-\ obliteration\\:\\ 0\\.04285676800447109\ \(0\)\
\-\ forming\\:\\ 0\\.04260196638887341\ \(0\)\
\-\ therapy\\:\\ 0\\.0425856190733457\ \(0\)\
\-\ are\\:\\ 0\\.04218663600850213\ \(0\)\
\-\ demonstration\\:\\ 0\\.04212051591244687\ \(0\)\
\-\ these\\:\\ 0\\.041854443517829465\ \(0\)\
\-\ periodic\\:\\ 0\\.04167229624211874\ \(0\)\
\-\ uti\\:\\ 0\\.04125301474180869\ \(0\)\
\-\ consisting\\:\\ 0\\.04125301474180869\ \(0\)\
\-\ laparoscopic\\:\\ 0\\.04067083963647363\ \(0\)\
\-\ is\\:\\ 0\\.040595455739987296\ \(0\)\
\-\ units\\:\\ 0\\.03918414554850791\ \(0\)\
\-\ endoscopic\\:\\ 0\\.03875564245910186\ \(0\)\
\-\ scarring\\:\\ 0\\.038225012274486485\ \(0\)\
\-\ this\\:\\ 0\\.038202438177010946\ \(0\)\
\-\ febrile\\:\\ 0\\.03809886057426454\ \(0\)\
\-\ longer\\:\\ 0\\.03773446927253467\ \(0\)\
\-\ provide\\:\\ 0\\.037502422876093774\ \(0\)\
\-\ sharp\\:\\ 0\\.03645230230936663\ \(0\)\
\-\ managed\\:\\ 0\\.036261211814854775\ \(0\)\
\-\ patient\\:\\ 0\\.03616031472424477\ \(0\)\
\-\ surgical\\:\\ 0\\.03602378349915762\ \(0\)\
\-\ contrast\\:\\ 0\\.036012440663994075\ \(0\)\
\-\ culture\\:\\ 0\\.03589510885235164\ \(0\)\
\-\ requires\\:\\ 0\\.03589510885235164\ \(0\)\
\-\ behind\\:\\ 0\\.035719514151536624\ \(0\)\
\-\ treatment\\:\\ 0\\.03530635364159678\ \(0\)\
\-\ determined\\:\\ 0\\.035300232651226573\ \(0\)\
\-\ late\\:\\ 0\\.03498326205951241\ \(0\)\
\-\ mechanism\\:\\ 0\\.03490637822222996\ \(0\)\
\-\ collecting\\:\\ 0\\.03475528749550023\ \(0\)\
\-\ undergo\\:\\ 0\\.0346076309480112\ \(0\)\
\-\ annual\\:\\ 0\\.03425253664449299\ \(0\)\
\-\ valve\\:\\ 0\\.03398180545386731\ \(0\)\
\-\ invasive\\:\\ 0\\.03372190645987761\ \(0\)\
\-\ close\\:\\ 0\\.03353358578353917\ \(0\)\
\-\ options\\:\\ 0\\.03341100462939629\ \(0\)\
\-\ gross\\:\\ 0\\.032886329719216935\ \(0\)\
\-\ therefore\\:\\ 0\\.032666084612900985\ \(0\)\
\-\ visible\\:\\ 0\\.032666084612900985\ \(0\)\
\-\ angle\\:\\ 0\\.03250566637785347\ \(0\)\
\-\ slight\\:\\ 0\\.032453061973618344\ \(0\)\
\-\ injection\\:\\ 0\\.03224680311259094\ \(0\)\
\-\ afebrile\\:\\ 0\\.03199786045583979\ \(0\)\
\-\ regular\\:\\ 0\\.03199786045583979\ \(0\)\
\-\ showing\\:\\ 0\\.03199786045583979\ \(0\)\
\-\ under\\:\\ 0\\.030676443333555157\ \(0\)\
\-\ either\\:\\ 0\\.030636708601570188\ \(0\)\
\-\ open\\:\\ 0\\.030636708601570188\ \(0\)\
\-\ young\\:\\ 0\\.030557960868584998\ \(0\)\
\-\ extends\\:\\ 0\\.03051894208206065\ \(0\)\
\-\ continued\\:\\ 0\\.030365169023159312\ \(0\)\
\-\ normal\\:\\ 0\\.030261897345027055\ \(0\)\
\-\ resolution\\:\\ 0\\.030068129472792752\ \(0\)\
\-\ described\\:\\ 0\\.030068129472792752\ \(0\)\
\-\ be\\:\\ 0\\.030066724353969922\ \(0\)\
\-\ recurrent\\:\\ 0\\.02971496598286124\ \(0\)\
\-\ condition\\:\\ 0\\.029612655074265352\ \(0\)\
\-\ recommended\\:\\ 0\\.02947869963925843\ \(0\)\
\-\ family\\:\\ 0\\.02915541859690013\ \(0\)\
\-\ term\\:\\ 0\\.029061490091900826\ \(0\)\
\-\ 80\\:\\ 0\\.02890789881478742\ \(0\)\
\-\ bladder\\:\\ 0\\.028757854999417184\ \(0\)\
\-\ complications\\:\\ 0\\.028383223904608065\ \(0\)\
\-\ hypertension\\:\\ 0\\.028355281459693824\ \(0\)\
\-\ history\\:\\ 0\\.028317380712281005\ \(0\)\
\-\ system\\:\\ 0\\.028272168064785524\ \(0\)\
\-\ failure\\:\\ 0\\.028135965834519362\ \(0\)\
\-\ to\\:\\ 0\\.027794045324255317\ \(0\)\
\-\ in\\:\\ 0\\.02765724309073278\ \(0\)\
\-\ antibiotics\\:\\ 0\\.027302248455184298\ \(0\)\
\-\ above\\:\\ 0\\.026734994056418455\ \(0\)\
\-\ iv\\:\\ 0\\.026479356810434743\ \(0\)\
\-\ girl\\:\\ 0\\.025996414404175636\ \(0\)\
\-\ complete\\:\\ 0\\.025977050430294663\ \(0\)\
\-\ labs\\:\\ 0\\.025674828104681285\ \(0\)\
\-\ although\\:\\ 0\\.02522906973706391\ \(0\)\
\-\ less\\:\\ 0\\.025211860168252366\ \(0\)\
\-\ recent\\:\\ 0\\.02509265299934623\ \(0\)\
\-\ followed\\:\\ 0\\.025025503994023642\ \(0\)\
\-\ first\\:\\ 0\\.025008824630747963\ \(0\)\
\-\ unremarkable\\:\\ 0\\.02484434474603559\ \(0\)\
\-\ central\\:\\ 0\\.02474761926063737\ \(0\)\
\-\ long\\:\\ 0\\.024573945023479437\ \(0\)\
\-\ positive\\:\\ 0\\.024419989751967235\ \(0\)\
\-\ often\\:\\ 0\\.02418100709422721\ \(0\)\
\-\ will\\:\\ 0\\.02385217564508495\ \(0\)\
\-\ approximately\\:\\ 0\\.02364635246178479\ \(0\)\
\-\ severe\\:\\ 0\\.023459961566665747\ \(0\)\
\-\ some\\:\\ 0\\.023317173216052957\ \(0\)\
\-\ age\\:\\ 0\\.023266018554686622\ \(0\)\
\-\ only\\:\\ 0\\.023152372360592397\ \(0\)\
\-\ treated\\:\\ 0\\.023077697878348184\ \(0\)\
\-\ negative\\:\\ 0\\.022942984865540004\ \(0\)\
\-\ years\\:\\ 0\\.02271668231503012\ \(0\)\
\-\ month\\:\\ 0\\.022543429156293912\ \(0\)\
\-\ on\\:\\ 0\\.022384919256369398\ \(0\)\
\-\ all\\:\\ 0\\.022060350661207723\ \(0\)\
\-\ secondary\\:\\ 0\\.021965814674822757\ \(0\)\
\-\ shows\\:\\ 0\\.021750437765383043\ \(0\)\
\-\ mild\\:\\ 0\\.021007703828594532\ \(0\)\
\-\ more\\:\\ 0\\.020349364771669747\ \(0\)\
\-\ physical\\:\\ 0\\.0200942504357453\ \(0\)\
\-\ can\\:\\ 0\\.01944739875400869\ \(0\)\
\-\ diagnosis\\:\\ 0\\.01921113241040588\ \(0\)\
\-\ it\\:\\ 0\\.018969993488439706\ \(0\)\
\-\ exam\\:\\ 0\\.01865552833772356\ \(0\)\
\-\ have\\:\\ 0\\.018513012375883674\ \(0\)\
\-\ but\\:\\ 0\\.018325742448949474\ \(0\)\
\-\ well\\:\\ 0\\.017944159336640425\ \(0\)\
\-\ seen\\:\\ 0\\.01744708574624622\ \(0\)\
\-\ within\\:\\ 0\\.017068241051768452\ \(0\)\
\-\ that\\:\\ 0\\.016082224162302795\ \(0\)\
\-\ by\\:\\ 0\\.015737408487909322\ \(0\)\
\-\ from\\:\\ 0\\.014718270921326838\ \(0\)\
\-\ an\\:\\ 0\\.014171244192756711\ \(0\)\
\-\ at\\:\\ 0\\.013997660358916605\ \(0\)\
\-\ left\\:\\ 0\\.012641639392374492\ \(0\)\
